HR Execs on the Move

Relay Therapeutics

www.relaytx.com

 
Relay Therapeutics is building the world`s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. By placing protein motion at the heart of drug discovery, Relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. Headquartered in Cambridge, Mass., Relay Therapeutics is a private company launched in 2016. To date, Relay Therapeutics has raised $120M in financing from Third Rock ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.relaytx.com
  • 215 First Street 3rd Floor
    Cambridge, MA USA 02142
  • Phone: 617.370.8837

Executives

Name Title Contact Details
Donald Bergstrom
 President of Research and Development Profile
Joe Lussier
 Associate Director, Financial Planning and Analysis Profile
Rory Anderson
 Senior Director, People Business Partner Profile
Michael Levy
 Senior Director, Accounting Profile
Briana Snyder
 Senior Director, People Business Partner Profile

Similar Companies

Rho

Welcome to a different kind of CRO. Bringing your product to market takes something different. At Rho, we`re experienced, creative problem-solvers who provide outstanding clinical research fueled by our unique team approach. Our dedication to collaboration makes your clinical trials and programs run smarter and more efficiently.

Allen Davis and Associates

Allen Davis & Associates is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BioTime

BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.

Aderans Research Institute

Aderans Research Institute is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vytelle

With Vytelle, cattle producers increase accuracy of feed intake and bodyweight measurement, improve certainty of genetic selection and accelerate progress.